Veronese Federica

22PUBLICATIONS
89CO-AUTHORS
AllergyPharmacogenomicsEpidemiological methodsFood properties (incl. characteristics and health benefits)Virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 22, 2026
Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.

|Apr 15, 2026
Dupilumab for Prurigo Nodularis: Real-World Outcomes Up to 104 Weeks from the DUPItaPN Study.

|Apr 15, 2026
Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis).

Elena Pezzolo, Rossi Mariateresa, Raul Armando Luyo Saboya

|Oct 10, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.

Gianluca Avallone, Andrea Bombelli, Luigi Gargiulo

|Sep 22, 2025
Safety and Effectiveness of Dupilumab in Atopic Dermatitis Patients with Hematologic Comorbidities: A Multicenter, Retrospective Study.

Luca Bettolini, Stefano Bighetti, Silvia Mariel Ferrucci

|Jun 03, 2025
Skin microbiota in atopic dermatitis: victim or executioner?

Chiara Maria Teresa Boggio, Federica Veronese, Marta Armari

Pageof 4

Frequent Collaborators

15 joint publications

Paola Savoia

12 joint publications

Elisa Zavattaro

5 joint publications

Elia Esposto

4 joint publications

Maddalena Napolitano